Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Clinical trial NCT06297096 · RECRUITING
Trial details
- NCT number
- NCT06297096
- Sponsor
- National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-12-30
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.